<DOC>
	<DOCNO>NCT00277914</DOCNO>
	<brief_summary>To estimate duration efficacy continue treatment double-blind flibanserin placebo twenty-four week treatment .</brief_summary>
	<brief_title>Flibanserin Randomized Withdrawal Trial Pre-menopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Sexual Dysfunctions , Psychological</mesh_term>
	<criteria>1 . Women 18 premenopausal 2 . FSDSR 14 3 . Willingness try sexual activity least monthly 4 . Willingness use electronic diary daily 5 . Stable , monogamous , heterosexual relationship least one year 6 . Medically acceptable method contraception 1 . Clinically relevant condition might interfere patient 's abil ity participate trial 2 . Specified medication 3 . Sexual function affect medication 4 . Drug dependence abuse 5 . Sexual partner need treatment 6 . PeriMenopause Menopause ( surgical otherwise ) 7 . Pregnancy 8 . Pelvic Inflammatory Disease 9 . Major depressive Episode 10 . Significant ECG abnormalities 11 . Significant Neurologic finding 12 . Significant GI , Hepatic , Cardiovascular , Renal , Hematologic , Immunologic Respiratory finding 13 . Uncorrected thyroid endocrine disease 14 . Uncontrolled Glaucoma</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>